| Literature DB >> 30011910 |
Gerald T Mangine1, Trisha A Van Dusseldorp2, Yuri Feito3, Alyssa J Holmes4, Paul R Serafini5, Allyson G Box6, Adam M Gonzalez7.
Abstract
To determine the salivary steroid response to high-intensity functional training (HIFT) competition workouts, saliva samples were collected from ten recreationally trained male and female competitors during a 5-week (WK1⁻WK5) international competition. Competitors arrived at their local affiliate and provided samples prior to (PRE) their warm-up, immediately (IP), 30-min (30P), and 60-min (60P) post-exercise. Samples were analyzed for concentrations of testosterone (T), cortisol (C), and their ratio (TC). Generalized linear mixed models with repeated measures revealed significant main effects for time (p < 0.001) for T, C, and TC. Compared to PRE-concentrations, elevated (p < 0.05) T was observed at IP on WK2⁻WK5 (mean difference: 135⁻511 pg·mL-1), at 30P on WK3 (mean difference: 81.0 ± 30.1 pg·mL-1) and WK5 (mean difference: 56.6 ± 22.7 pg·mL-1), and at 60P on WK3 (mean difference: 73.5 ± 29.7 pg·mL-1) and WK5 (mean difference: 74.3 ± 28.4 pg·mL-1). Compared to PRE-concentrations, elevated (p < 0.05) C was noted on all weeks at IP (mean difference: 9.3⁻15.9 ng·mL-1) and 30P (mean difference: 6.0⁻19.9 ng·mL-1); significant (p < 0.006) elevations were noted at 60P on WK1 (mean difference: 9.1 ± 3.0 ng·mL-1) and WK5 (mean difference: 12.8 ± 2.9 ng·mL-1). Additionally, TC was significantly reduced from PRE-values by 61% on WK1 at 60P (p = 0.040) and by 80% on WK5 at 30P (p = 0.023). Differences in T, C, and TC were also observed between weeks at specific time points. Although each workout affected concentrations in T, C, and/or the TC ratio, changes appeared to be modulated by the presence of overload and workout duration. During periods of elevated training or competition, athletes and coaches may consider monitoring these hormones for consistency and as a means of assessing workout difficulty.Entities:
Keywords: CrossFit®; acute endocrine response; salivary steroid; testosterone-to-cortisol ratio
Year: 2018 PMID: 30011910 PMCID: PMC6162535 DOI: 10.3390/sports6030062
Source DB: PubMed Journal: Sports (Basel) ISSN: 2075-4663
Weekly event challenges for (male/female) competitors in the 2016 CrossFit® Open.
| Week | Scoring | Rx | Scaled |
|---|---|---|---|
| WK1 | 20-min AMRAP | 25-ft overhead walking lunge (95/65 lbs.) | 25-ft front rack walking lunge (45/35 lbs.) |
| WK2 | AMRAP or TTC * | 25 toes-to-bar | 25 hanging knee raises |
| WK3 | 7-min AMRAP | 10 power snatches (75/55 lbs.) | 10 power snatches (45/35 lbs.) |
| WK4 | 13-min AMRAP | 55 deadlifts (225/155 lbs.) | 55 deadlifts (135/95 lbs.) |
| WK5 | TTC | thrusters (95/65 lbs.) | thrusters (65/45 lbs.) |
Note: AMRAP = As many repetitions as possible; Rx = As prescribed; TTC = Time to completion; * On WK2, competitors were allotted 4-min to complete the initial round of 90 repetitions (toes-to-bar, double-unders and squat cleans). Competitors progressed to the next round and received an additional 4 min if they completed all repetitions within the time cap, otherwise their workout was concluded. Progression continued this way until all 5 rounds were completed where TTC would distinguish performance.
Competitor level and performance scores during each week of the 2016 CrossFit® Open.
| Participants | Week 1 | Week 2 | Week 3 | Week 4 | Week 5 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Level | Repetitions | Level | Rounds | Repetitions | Level | Repetitions | Level | Repetitions | Level | Minutes | |
| Women | |||||||||||
| Participant #1 | Scale | 297 | Scale | 5 | 430 | Scaled | 143 | Scale | 278 | Scale | 13.78 |
| Participant #2 | Scale | 216 | Rx | 1 | 79 | Rx | 10 | Scale | 165 | Rx | 18.38 |
| Participant #3 | Scale | 135 | Scale | 4 | 348 | Scale | 49 | Scale | 121 | Rx | 26.98 |
| Participant #4 | Scale | 218 | Rx | 2 | 20 | Scale | 108 | Rx | 165 | Rx | 19.93 |
| Participant #5 | Rx | 669 | Rx | 2 | 167 | Rx | 58 | Scale | 217 | Rx | 15.25 |
| Mean ± SD | 307 ± 210 | 3 ± 2 | 209 ± 175 | 74 ± 52 | 189 ± 60 | 18.87 ± 5.15 | |||||
| Men | |||||||||||
| Participant #6 | Rx | 685 | Rx | 2 | 165 | Rx | 75 | Rx | 178 | - | - |
| Participant #7 | Rx | 791 | Rx | 2 | 173 | Rx | 90 | Rx | 199 | Rx | 13.47 |
| Participant #8 | Rx | 681 | Rx | 2 | 172 | Rx | 71 | Rx | 184 | Rx | 14.47 |
| Participant #9 | Rx | 681 | Rx | 2 | 175 | Rx | 75 | Rx | 182 | Rx | 18.38 |
| Participant #10 | Rx | 720 | Rx | 2 | 126 | Rx | 89 | Rx | 193 | - | - |
| Mean ± SD | 719 ± 51 | 2 ± 0 | 162 ± 21 | 80 ± 9 | 187 ± 9 | - | 15.44 ± 2.60 | ||||
| All Participants | 490 ± 265 | 2 ± 1 | 186 ± 120 | 77 ± 35 | 188 ± 41 | 17.58 ± 4.50 | |||||
Individual testosterone (pg·mL−1) responses during each week of the 2016 CrossFit® Open.
| Participants | Week 1 | Week 2 | Week 3 | Week 4 | Week 5 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PRE | IP | 30P | 60P | PRE | IP | 30P | 60P | PRE | IP | 30P | 60P | PRE | IP | 30P | 60P | PRE | IP | 30P | 60P | |
| Women | ||||||||||||||||||||
| Participant #1 | 266 | 377 | 283 | 340 | 871 | 1222 | 563 | 686 | 202 | 1002 | 391 | 405 | 1479 | 4207 | 1250 | 704 | 186 | 661 | 387 | 375 |
| Participant #2 | 180 | 591 | 280 | 159 | 232 | 660 | 361 | 273 | 148 | 333 | 297 | 239 | 59 | 225 | 98 | 38 | 21 | 41 | 42 | 29 |
| Participant #3 | 67 | 127 | 99 | 84 | 79 | 110 | 112 | 73 | 72 | 71 | 95 | 84 | 89 | 81 | 117 | 89 | 69 | 87 | 102 | 53 |
| Participant #4 | 59 | 396 | 132 | 110 | 89 | 197 | 66 | 44 | 46 | 296 | 62 | 102 | 78 | 361 | 160 | 55 | 36 | 256 | 121 | 78 |
| Participant #5 | 90 | 261 | 166 | 103 | 74 | 148 | 169 | 114 | 85 | 172 | 176 | 161 | 99 | 135 | 157 | 44 | 78 | 174 | 100 | 100 |
| Men | ||||||||||||||||||||
| Participant #6 | 452 | 609 | 311 | 138 | 224 | 684 | 365 | 192 | 230 | 592 | 217 | 156 | 375 | 471 | 315 | 289 | - | - | - | - |
| Participant #7 | 74 | 152 | 98 | 67 | 81 | 143 | 86 | 56 | 86 | 140 | 106 | 93 | 72 | 140 | 151 | 85 | 78 | 108 | 111 | 109 |
| Participant #8 | 194 | 213 | 254 | 162 | 268 | 843 | 389 | 186 | 168 | 303 | 198 | 176 | 358 | 346 | 361 | 236 | 136 | 365 | 230 | 217 |
| Participant #9 | - | - | - | - | 77 | 118 | 102 | 120 | 104 | 127 | 98 | 197 | 93 | 158 | 93 | 178 | 94 | 101 | 74 | 267 |
| Participant #10 | 134 | 1685 | 358 | 205 | 95 | 750 | 203 | 224 | 154 | 826 | 466 | 418 | 290 | 1974 | 475 | 204 | - | - | - | - |
Figure 1Mean changes in testosterone concentrations during each week of the CrossFit® Open (mean difference ±95% Confidence Interval). * = Significantly (p < 0.05) different from PRE-scores; # = Significantly (p < 0.05) different from WK5.
Individual cortisol (ng·mL−1) responses during each week of the 2016 CrossFit® Open.
| Participants | Week 1 | Week 2 | Week 3 | Week 4 | Week 5 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PRE | IP | 30P | 60P | PRE | IP | 30P | 60P | PRE | IP | 30P | 60P | PRE | IP | 30P | 60P | PRE | IP | 30P | 60P | |
| Women | ||||||||||||||||||||
| Participant #1 | 12.0 | 13.0 | 19.5 | 19.0 | 15.9 | 22.7 | 18.8 | 19.7 | 11.3 | 23.1 | 17.3 | 15.1 | 12.4 | 31.8 | 16.1 | 12.0 | 3.9 | 16.9 | 29.0 | 20.4 |
| Participant #2 | 4.3 | 18.0 | 18.6 | 17.1 | 14.9 | 22.6 | 15.5 | 8.8 | 2.9 | 9.1 | 4.9 | 6.0 | 6.4 | 15.8 | 17.2 | 17.9 | 1.7 | 3.6 | 4.4 | 4.7 |
| Participant #3 | 7.7 | 25.7 | 25.8 | 13.6 | 4.1 | 22.9 | 38.2 | 22.5 | 8.0 | 10.9 | 9.2 | 5.0 | 5.4 | 16.4 | 33.4 | 49.9 | 3.9 | 35.3 | 46.4 | 20.0 |
| Participant #4 | 6.1 | 37.3 | 34.4 | 29.6 | 6.4 | 11.5 | 11.6 | 6.5 | 6.5 | 27.9 | 23.8 | 18.4 | 24.2 | 36.8 | 35.1 | 22.5 | 4.0 | 35.9 | 41.1 | 36.2 |
| Participant #5 | 6.4 | 30.3 | 36.3 | 19.2 | 4.3 | 21.8 | 29.4 | 15.1 | 7.2 | 16.6 | 16.2 | 8.3 | 6.6 | 12.0 | 9.4 | 5.0 | 3.2 | 9.6 | 26.0 | 23.1 |
| Men | ||||||||||||||||||||
| Participant #6 | 6.8 | 15.7 | 10.4 | 6.5 | 8.8 | 11.4 | 9.5 | 4.8 | 3.6 | 11.8 | 6.9 | 5.2 | 5.4 | 20.0 | 10.9 | 4.1 | - | - | - | - |
| Participant #7 | 3.3 | 21.0 | 14.8 | 11.3 | 4.7 | 13.8 | 8.5 | 5.0 | 8.8 | 14.4 | 8.4 | 4.5 | 1.5 | 10.9 | 8.1 | 5.3 | 0.8 | 12.4 | 14.4 | 9.3 |
| Participant #8 | 12.2 | 18.8 | 23.0 | 24.8 | 19.0 | 26.9 | 24.5 | 7.8 | 14.9 | 19.4 | 19.4 | 14.2 | 18.5 | 20.4 | 26.0 | 16.2 | 6.1 | 13.3 | 30.7 | 21.1 |
| Participant #9 | - | - | - | - | 6.3 | 8.9 | 8.8 | 9.7 | 6.1 | 11.4 | 8.5 | 7.6 | 5.6 | 16.9 | 18.8 | 13.4 | 2.9 | 3.4 | 5.4 | 3.6 |
| Participant #10 | 28.8 | 54.4 | 39.7 | 34.4 | 12.4 | 35.6 | 25.5 | 17.7 | 11.5 | 29.0 | 25.7 | 17.8 | 23.8 | 46.2 | 28.2 | 22.8 | - | - | - | - |
Figure 2Mean percent changes in cortisol concentrations during each week of the CrossFit® Open (mean difference ±95% Confidence Interval). * = Significantly (p < 0.05) different from PRE-scores. # = Significantly (p < 0.05) different from WK1.
Figure 3Mean changes in the testosterone-cortisol ratio during each week of the CrossFit® Open (mean difference ±95% Confidence Interval). * = Significantly (p < 0.05) different from PRE-scores. # = Significantly (p < 0.05) different from WK1. † = Significantly (p < 0.05) different from WK5.